Works matching DE "FILGRASTIM"

Results: 396

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study.

Published in:

2004

By:

Frasci, Giuseppe;
Comella, Pasquale;
Thomas, Renato;
Di Bonito, Maurizio;
Lapenta, Liliana;
Capasso, Immacolata;
Botti, Gerardo;
Vallone, Paolo;
De Rosa, Vincenzo;
D'Aiuto, Giuseppe;
Comella, Giuseppe

Publication type:

journal article

Complete sequencing of the recombinant granulocyte-colony stimulating factor (filgrastim) and detection of biotinylation by mass spectrometry.

Published in:

Amino Acids, 2010, v. 38, n. 4, p. 1043, doi. 10.1007/s00726-009-0312-1

By:

Ahmed, Kareem Eldin A. M.;
Wei-Qiang Chen;
John, Julius Paul Pradeep;
Sung Ung Kang;
Lubec, Gert

Publication type:

Article

Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation.

Published in:

Oncology, 2010, v. 79, n. 1/2, p. 93, doi. 10.1159/000320604

By:

Samaras, Panagiotis;
Buset, Elefteri M.;
Siciliano, Raffaele Daniele;
Haile, Sarah R.;
Petrausch, Ulf;
Mischo, Axel;
Honegger, Hanspeter;
Pestalozzi, Bernhard C.;
Schanz, Urs;
Stussi, Georg;
Stahel, Rolf A.;
Knuth, Alexander;
Renner, Christoph;
Stenner-Liewen, Frank

Publication type:

Article

Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group

Published in:

Oncology, 2009, v. 77, n. 2, p. 107, doi. 10.1159/000229504

By:

Skarlos, Dimosthenis V.;
Timotheadou, Eleni;
Galani, Eleni;
Samantas, Epaminondas;
Grimani, Irene;
Lianos, Evangelos;
Aravantinos, Gerasimos;
Xanthakis, Ioannis;
Pentheroudakis, George;
Pectasides, Dimitrios;
Fountzilas, George

Publication type:

Article

Biological Effects of Pegfilgrastim on Circulating Neutrophils in Breast Cancer Patients Undergoing Dose-Dense Chemotherapy.

Published in:

Oncology, 2008, v. 75, n. 3/4, p. 237, doi. 10.1159/000164588

By:

Invernizzi, Rosangela;
Grasso, Donatella;
Travaglino, Erica;
Benatti, Chiara;
Collovà, Elena;
Manzoni, Mariangela;
Livraghi, Luca;
Danova, Marco;
Riccardi, Alberto

Publication type:

Article

Frequency of Febrile Neutropenia in Breast Cancer Patients Receiving Epirubicin and Docetaxel/Paclitaxel with Colony-Stimulating Growth Factors: A Comparison of Filgrastim or Lenograstim with Pegfilgrastim.

Published in:

Oncology, 2006, v. 70, n. 4, p. 290, doi. 10.1159/000094890

By:

Schippinger, Walter;
Holub, Robert;
Dandachi, Nadia;
Bauernhofer, Thomas;
Samonigg, Hellmut

Publication type:

Article

PROGNOSTIC ROLE OF FILGRASTIM IN THE EFFECTIVENESS OF PD-1/PD-L1 INHIBITORS IN PREVIOUSLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER.

Published in:

Farmacia, 2023, v. 71, n. 3, p. 556, doi. 10.31925/farmacia.2023.3.14

By:

MARIN POZO, JUAN FRANCISCO;
MUÑOZ CID, CARMEN LUCIA;
CLARAMUNT GARCIA, RAQUEL;
MARIN CABA, ELVIRA;
ORTEGA GRANADOS, ANA LAURA

Publication type:

Article

Two decades of pegfilgrastim: what have we learned? Where do we go from here?

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 5, p. 707, doi. 10.1080/03007995.2023.2196197

By:

De Oliveira Brandao, Cisio;
Lewis, Sandra;
Sandschafer, Darcie;
Crawford, Jeffrey

Publication type:

Article

Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 3, p. 766, doi. 10.4143/crt.2022.987

By:

Yong Wha Moon;
Seung Ki Kim;
Keun Seok Lee;
Moon Hee Lee;
Yeon Hee Park;
Kyong Hwa Park;
Gun Min Kim;
Seungtaek Lim;
Seung Ah Lee;
Jae Duk Choi;
Eunhye Baek;
Hyesun Han;
Seungjae Baek;
Seock-Ah Im

Publication type:

Article

Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168

By:

Seong Hyun Jeong;
Seok Jin Kim;
Dok Hyun Yoon;
Yong Park;
Hye Jin Kang;
Youngil Koh;
Gyeong-Won Lee;
Won-Sik Lee;
Deok-Hwan Yang;
Young Rok Do;
Min Kyoung Kim;
Kwai Han Yoo;
Yoon Seok Choi;
Hwan Jung Yun;
Jun Ho Yi;
Jae-Cheol Jo;
Hyeon-Seok Eom;
Jae-Yong Kwak;
Ho-Jin Shin;
Byeong Bae Park

Publication type:

Article

Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1256, doi. 10.4143/crt.2021.944

By:

Do Young Kim;
Jehyun Nam;
Joo-Seop Chung;
Byeol Eun Jeon;
Ji Hyun Lee;
Jae-Cheol Jo;
Sang-Woo Kim;
Ho-Jin Shin

Publication type:

Article

Experimental Study of the Effectiveness of Naphazoline and Co-Administration of Filgrastim in Combined Radiation Injury.

Published in:

Biology Bulletin, 2023, v. 50, n. 11, p. 3054, doi. 10.1134/S1062359023110183

By:

Ponomarev, D. B.;
Remizov, D. V.;
Kondakov, A. Yu.;
Drachyov, I. S.;
Tikhomirov, P. V.;
Kudryashov, V. S.

Publication type:

Article

Experimental Study of the Effectiveness of Naphazoline and Co-Administration of Filgrastim in Combined Radiation Injury.

Published in:

Biology Bulletin, 2023, v. 50, n. 10, p. 3054, doi. 10.1134/S1062359023110183

By:

Ponomarev, D. B.;
Remizov, D. V.;
Kondakov, A. Yu.;
Drachyov, I. S.;
Tikhomirov, P. V.;
Kudryashov, V. S.

Publication type:

Article

Anemia hemolítica autoinmune en paciente pediátrico con infección por SARSCoV 2: reporte de un caso en Medellín, Colombia.

Published in:

Salud Uninorte, 2024, v. 40, n. 1, p. 305, doi. 10.14482/sun.40.01.787.658

By:

NOREÑA GÓMEZ, SARA ISABEL;
ATUESTA LONDOÑO, MARÍA ADELAIDA;
ESCOBAR GONZÁLEZ, ANDRÉS FELIPE

Publication type:

Article

Reduction of biologic pricing following biosimilar introduction: Analysis across 57 countries and regions, 2012–19.

Published in:

PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304851

By:

Chen, Hui-Han;
Yemeke, Tatenda;
Ozawa, Sachiko

Publication type:

Article

Analytical sameness methodology for the evaluation of structural, physicochemical, and biological characteristics of Armlupeg: A pegfilgrastim biosimilar case study.

Published in:

PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0289745

By:

Deshmukh, Arati;
Goyal, Rishank;
Sundaram, Kalyana;
Dange, Kaustubh;
Lakhote, Tejshri;
Niranjan, Sanjay;
Bharucha, Jennifer;
Mishra, Ashok;
Vats, Bhavesh;
Tiwari, Sanjay

Publication type:

Article

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs.

Published in:

Journal of Veterinary Internal Medicine, 2022, v. 36, n. 1, p. 234, doi. 10.1111/jvim.16325

By:

Lawson, Haylie C.;
Musser, Margaret L.;
Regan, Rebecca;
Moore, Antony S.;
Hohenhaus, Ann;
Flesner, Brian;
Johannes, Chad M.

Publication type:

Article

Comparison of the efficacy of a generic plerixafor versus Mozobil as adjunct peripheral blood stem cell mobilization agents in multiple myeloma patients.

Published in:

Transfusion, 2024, v. 64, n. 12, p. 2332, doi. 10.1111/trf.18033

By:

Yuan, Shan;
Chang, Shelley;
Kim, Hoim;
Wang, Shirong

Publication type:

Article

Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.

Published in:

Transfusion, 2024, v. 64, n. 8, p. 1402, doi. 10.1111/trf.17909

By:

Shahzad, Moazzam;
Amin, Muhammad Kashif;
Bellman, Polina;
Al‐Ramahi, Joe;
Noor, Jawad;
Vyas, Abhinav;
Mahmoudjafari, Zahra;
McGuirk, Matthew;
DeJarnette, Shaun;
Ahmed, Nausheen;
Abdallah, Al‐Ola;
Shune, Leyla;
Singh, Anurag K.;
McGuirk, Joseph P.;
Abhyankar, Sunil;
Mushtaq, Muhammad Umair

Publication type:

Article

Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).

Published in:

2022

By:

Vucinic, Vladan;
Jentzsch, Madlen;
Leiblein, Sabine;
Bach, Enrica;
Remane, Yvonne;
Schulze‐Forster, Kai;
Cross, Michael;
Pönisch, Wolfram;
Schwind, Sebastian;
Franke, Georg‐Nikolaus;
Platzbecker, Uwe;
Niederwieser, Dietger;
Schulze-Forster, Kai;
Franke, Georg-Nikolaus

Publication type:

journal article

Comparison of CD34<sup>+</sup> cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study.

Published in:

Transfusion, 2021, v. 61, n. 11, p. 3202, doi. 10.1111/trf.16645

By:

Anu, Partanen;
Antti, Turunen;
Raija, Silvennoinen;
Marja, Pyörälä;
Jaakko, Valtola;
Timo, Siitonen;
Mervi, Putkonen;
Marja, Sankelo;
Anu, Sikiö;
Karri, Penttilä;
Taru, Kuittinen;
Jukka, Pelkonen;
Pentti, Mäntymaa;
Esa, Jantunen;
Ville, Varmavuo

Publication type:

Article

Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34<sup>+</sup> cells in non‐Hodgkin lymphoma patients.

Published in:

Transfusion, 2019, v. 59, n. 1, p. 325, doi. 10.1111/trf.14993

By:

Partanen, A.;
Valtola, J.;
Ropponen, A.;
Kuitunen, H.;
Kuittinen, O.;
Vasala, K.;
Ågren, L.;
Penttilä, K.;
Keskinen, L.;
Pyörälä, M.;
Nousiainen, T.;
Selander, T.;
Mäntymaa, P.;
Pelkonen, J.;
Varmavuo, V.;
Jantunen, E.

Publication type:

Article

A case of filgrastim-induced neutrophilic dermatosis of the dorsal hands in a patient with Felty syndrome.

Published in:

2023

By:

Joshi, Tejas P.;
Dokic, Yelena;
Verstovsek, Gordana;
Rosen, Theodore

Publication type:

Case Study

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis.

Published in:

2019

By:

Mansell, Kerry;
Bhimji, Hishaam;
Eurich, Dean;
Mansell, Holly

Publication type:

corrected article

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis.

Published in:

2019

By:

Mansell, Kerry;
Bhimji, Hishaam;
Eurich, Dean;
Mansell, Holly

Publication type:

journal article

Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study.

Published in:

2019

By:

Laribi, Kamel;
Badinand, Delphine;
Janoray, Philippe;
Benabed, Khaled;
Mouysset, Jean-Loup;
Fabre, Elizabeth;
Monchecourt, Françoise;
Diab, Rafik

Publication type:

journal article

Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24–72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study

Published in:

2019

By:

Ludwig, Heinz;
Gascón, Pere;
Bokemeyer, Carsten;
Aapro, Matti;
Boccadoro, Mario;
MacDonald, Karen;
Denhaerynck, Kris;
Abraham, Ivo;
Krendyukov, Andriy

Publication type:

journal article

Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study.

Published in:

2019

By:

Salmon, Jean Paul;
Smakal, Martin;
Karanikiotis, Charisios;
Wojtukiewicz, Marek Z.;
Omnes, Yohann;
DeCosta, Lucy;
Wetten, Sally;
O'Kelly, James

Publication type:

journal article

A single-arm, retrospective analysis of the incidence of febrile neutropenia using same-day versus next-day pegfilgrastim in patients with gastrointestinal cancers treated with FOLFOX or FOLFIRI.

Published in:

2019

By:

Eckstrom, John;
Bartels, Trace;
Abraham, Ivo;
Patel, Hitendra;
Elquza, Emad;
Scott, Aaron J;
Malangone, Steven;
Hollings, Jerrelee;
McBride, Ali

Publication type:

journal article

Filgrastim use in patients receiving chemotherapy for early-stage breast cancer-a survey of physicians and patients.

Published in:

2018

By:

Hilton, John;
Vandermeer, Lisa;
Sienkiewicz, Marta;
Mazzarello, Sasha;
Hutton, Brian;
Stober, Carol;
Fergusson, Dean;
Blanchette, Phillip;
Joy, Anil A.;
Brianne Bota, A.;
Clemons, Mark

Publication type:

journal article

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim.

Published in:

2018

By:

Kirshner, Jeffrey J;
McDonald, Maxwell C 3rd;
Kruter, Flavio;
Guinigundo, Andrew S;
Vanni, Linda;
Maxwell, Cathy L;
Reiner, Maureen;
Upchurch, Terry E;
Garcia, Jacob;
Morrow, Phuong Khanh

Publication type:

journal article

A single-center, retrospective analysis to compare the efficacy and safety of filgrastim-sndz to filgrastim for prophylaxis of chemotherapy-induced neutropenia and for neutrophil recovery following autologous stem cell transplantation.

Published in:

2018

By:

Zecchini, Julia;
Yum, Kendra;
Steinberg, Amir;
Smith, Cardinale;
Kim, Sara

Publication type:

journal article

Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey.

Published in:

2018

By:

Hauber, A. Brett;
Mange, Brennan;
Price, Mark A.;
Wolin, Daniel;
Bensink, Mark;
Kaye, James A.;
Chandler, David

Publication type:

journal article

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.

Published in:

2018

By:

Dale, David C.;
Crawford, Jeffrey;
Klippel, Zandra;
Reiner, Maureen;
Osslund, Timothy;
Fan, Ellen;
Morrow, Phuong Khanh;
Allcott, Kim;
Lyman, Gary H.

Publication type:

journal article

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

Published in:

2017

By:

Aapro, Matti;
Link, Hartmut;
Sliwa, Thamer;
Tesch, Hans;
Valero, Vicente;
Boccia, Ralph;
Leonard, Robert;
Camps, Carlos;
Campone, Mario;
Choquet, Sylvain;
Danova, Marco;
Glaspy, John;
Hus, Iwona

Publication type:

journal article

Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.

Published in:

2017

By:

Cerchione, Claudio;
De Renzo, Amalia;
Di Perna, Maria;
Della Pepa, Roberta;
Pugliese, Novella;
Catalano, Lucio;
Pane, Fabrizio;
Picardi, Marco

Publication type:

journal article

Efficacy and safety of lipegfilgrastim compared with placebo in patients with non-small cell lung cancer receiving chemotherapy: post hoc analysis of elderly versus younger patients.

Published in:

2016

By:

Volovat, Constantin;
Bondarenko, Igor;
Gladkov, Oleg;
Buchner, Anton;
Lammerich, Andreas;
Müller, Udo;
Bias, Peter

Publication type:

journal article

Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone.

Published in:

2016

By:

Cerchione, Claudio;
Catalano, Lucio;
Peluso, Ilaria;
Nappi, Davide;
Di Perna, Maria;
Salvatore, Dalila;
Migliaccio, Ilaria;
Picardi, Marco;
Pane, Fabrizio

Publication type:

Letter

"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale.

Published in:

2016

By:

Marion, Sarah;
Tzivelekis, Spiros;
Darden, Christina;
Price, Mark;
Sherif, Bintu;
Garcia, Jacob;
Kaye, James;
Chandler, David;
Price, Mark A;
Kaye, James A

Publication type:

journal article

Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice.

Published in:

2016

By:

Weycker, Derek;
Li, Xiaoyan;
Barron, Rich;
Li, Yanli;
Reiner, Maureen;
Kartashov, Alex;
Figueredo, Jacqueline;
Tzivelekis, Spiros;
Garcia, Jacob

Publication type:

journal article

Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.

Published in:

2016

By:

Pettengell, Ruth;
Bias, Peter;
Mueller, Udo;
Lang, Nicole

Publication type:

journal article

Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study.

Published in:

2016

By:

Nahon, Sophie;
Rastkhah, Mansour;
Ben Abdelghani, Meher;
Soumoudronga, Ravaka-Fatoma;
Gasnereau, Isabelle;
Labourey, Jean-Luc

Publication type:

journal article

Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?

Published in:

2016

By:

Weycker, Derek;
Li, Xiaoyan;
Figueredo, Jacqueline;
Barron, Rich;
Tzivelekis, Spiros;
Hagiwara, May

Publication type:

journal article

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.

Published in:

2016

By:

Lambertini, Matteo;
Bruzzi, Paolo;
Poggio, Francesca;
Pastorino, Simona;
Gardin, Giovanni;
Clavarezza, Matteo;
Bighin, Claudia;
Pronzato, Paolo;
Mastro, Lucia;
Del Mastro, Lucia

Publication type:

journal article

Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.

Published in:

2016

By:

Brito, M.;
Esteves, S.;
André, R.;
Isidoro, M.;
Moreira, A.;
André, R

Publication type:

journal article

Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim.

Published in:

2016

By:

Xu, H.;
Gong, Q.;
Vogl, F.;
Reiner, M.;
Page, J.;
Vogl, F D;
Page, J H

Publication type:

journal article

Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).

Published in:

2016

By:

Gascón, Pere;
Aapro, Matti;
Ludwig, Heinz;
Bokemeyer, Carsten;
Boccadoro, Mario;
Turner, Matthew;
Denhaerynck, Kris;
MacDonald, Karen;
Abraham, Ivo;
Gascón, Pere

Publication type:

journal article

Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase II and III studies.

Published in:

2016

By:

Bondarenko, I.;
Bias, P.;
Buchner, A.;
Bondarenko, I M

Publication type:

journal article

Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study.

Published in:

2016

By:

Gladkov, Oleg;
Buchner, Anton;
Bias, Peter;
Müller, Udo;
Elsässer, Reiner;
Gladkov, Oleg A;
Müller, Udo;
Elsässer, Reiner

Publication type:

journal article

Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 7, p. 2045, doi. 10.1007/s00520-014-2555-y

By:

Kourlaba, Georgia;
Dimopoulos, Meletios;
Pectasides, Dimitrios;
Skarlos, Dimosthenis;
Gogas, Helen;
Pentheroudakis, George;
Koutras, Angelos;
Fountzilas, George;
Maniadakis, Nikos

Publication type:

Article